224
Views
14
CrossRef citations to date
0
Altmetric
Drug Evaluation

Tinidazole for the treatment of vaginal infections

&
Pages 743-751 | Published online: 26 Apr 2007

Bibliography

  • SOBEL JD: Vaginitis. N. Engl. J. Med. (1997) 337(26):1896-1903.
  • FREDRICKS DN, FIEDLER TL, MARRAZZO JM: Molecular identification of bacteria associated with bacterial vaginosis. N. Engl. J. Med. (2005) 353:1899-1911.
  • FERRIS MJ, MASZTAL A, ALDRIDGE KE, FORTENBERRY JD, FIDEL PL Jr, MARTIN DH: Association of Atopobium vaginae, a recently described metronidazole resistant anaerobe, with bacterial vaginosis. BMC Infect. Dis. (2004) 4:5.
  • AMSEL R, TOTTEN PA, SPIEGEL CA, CHEN KC, ESCHENBACH D, HOLMES KK: Nonspecific vaginitis: diagnostic criteria and microbial and epidemiologic associations. Am. J. Med. (1983) 74:14-22.
  • MORBIDITY AND MORTALITY WEEKLY REPORT: Sexually transmitted diseases treatment guidelines. (2006) 55(4):RR-11.
  • COTCH MF, PASTOREK JG II, NUGENT RP et al.: Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group. Sex. Transm. Dis. (1997) 24(6):353-360.
  • LAGA M, MANOKA A, KIVUVU M et al.: Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS (1993) 7(1):95-102.
  • PRICE MA, ZIMBA D, HOFFMAN IF et al.: Addition of treatment for trichomoniasis to syndromic management of urethritis in Malawi: a randomized clinical trial. Sex. Transm. Dis. (2003) 30(6):516-522.
  • LOSSICK JG, MULLER M, GORRELL TE: In vitro drug susceptibility and doses of metronidazole required for cure in cases of refractory vaginal trichomoniasis. J. Infect. Dis. (1986) 153(5):948-955.
  • MEINGASSNER JG, THURNER J: Strain of Trichomonas vaginalis resistant to metronidazole and other 5-nitroimidazoles. Antimicrob. Agents Chemother. (1979) 15(2):254-257.
  • SOBEL JD, NYIRJESY P, BROWN W: Tinidazole therapy for metronidazole-resistant vaginal trichomoniasis. Clin. Infect. Dis. (2001) 33(8):1341-1346.
  • FUNG HB, DOAN T: Tinidazole: a nitroimidazole antiprotozoal agent. Clin. Ther. (2005) 27(12):1859-1884.
  • NORD CE, KAGER L: Tinidazole – microbiology, pharmacology and efficacy in anaerobic infections. Infection (1983) 11(1):54-60.
  • LAMP KC, FREEMAN CD, KLUTMAN NE, LACY MK: Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials. Clin. Pharmacokinet. (1999) 36(5):353-373.
  • MATTILA J, MANNISTO PT, MANTYLA R, NYKANEN S, LAMMINSIVU U: Comparative pharmacokinetics of metronidazole and tinidazole as influenced by administration route. Antimicrob. Agents Chemother. (1983) 23:721-725.
  • MANNISTO P, KARHUNEN M, MATTILA J et al.: Concentrations of metronidazole and tinidazole in female reproductive organs after a single intravenous infusion and after repeated oral administration. Infection (1984) 12:197-201.
  • VIITANEN J, HAATAJA H, MANNISTO PT: Concentrations of metronidazole and tinidazole in abdominal tissues after a single intravenous infusion and repetitive oral administration. Chemotherapy (1984) 30(4):211-215.
  • CARMONA O, SILVA H, ACOSTA H: Vaginitis due to Gardnerella vaginalis: treatment with tinidazole. Curr. Ther. Res. (1983) 22:898-904.
  • MOHANTY KC, DEIGHTON R: Comparison of 2 g single dose of metronidazole, nimorazole and tinidazole in the treatment of vaginitis associated with Gardnerella vaginalis. J. Antimicrob. Chemother. (1987) 19:393-399.
  • AUSTIN MN, MEYN LA, HILLIER SL: Susceptibility of vaginal bacteria to metronidazole and tinidazole. Anaerobe (2006) 12(5-6):227-230.
  • SCHWEBKE JR, BARRIENTES FJ: Prevalence of Trichomonas vaginalis isolates with resistance to metronidazole and tinidazole. Antimicrob. Agents Chemother. (2006) 50(12):4209-4210.
  • CROWELL AL, SANDERS-LEWIS KA, SECOR WE: In vitro metronidazole and tinidazole activities against metronidazole-resistant strains of Trichomonas vaginalis. Antimicrob. Agents Chemother. (2003) 47(4):1407-1409.
  • MILANI M, BARCELLONA E, AGNELLO A: Efficacy of the combination of 2 g oral tinidazole and acidic buffering vaginal gel in comparison with vaginal clindamycin alone in bacterial vaginosis: a randomized, investigator-blinded, controlled trial. Eur. J. Obstet. Gynecol. Reprod. Biol. (2003) 109:67-71.
  • BURANAWARODOMKUL P, CHANDEYING V, SUTTHIJUMROON S: Seven day metronidazole versus single dose tinidazole as therapy for nonspecific vaginitis. J. Med. Assoc. Thai. (1990) 73:283-287.
  • SANZ SANZ F, HERNANZ AD, SANCHER EA, ALVAREZ CG, MUELAS M, RODRIGUEZ-NORIEGA A: Controlled comparative study of metronidazole (Flagyl) versus tinidazole (Tricolan) in the treatment of nonspecific vaginitis (vaginitis due to Gardnerella vaginalis). Rev. Esp. Obst. Gin. (1985) 44:717-720.
  • SCHINDLER EM, THAMM H, ANSMANN EB, SARNOW E, SCHINDLER AE: Treatment of bacterial vaginitis. Multicenter, randomized, open study with tinidazole in comparison with metronidazole. Fortschr. Med. (1991) 109(5):138-140.
  • SANZ F, ARREAZA L, VIDRIALES I, MIRANDA P, GRANDE J, VALLE R: Concerning the different therapeutic options for bacterial vaginosis. Progresos. de Obstet. y Ginecol. (1996) 39:669-674.
  • MILANI M, BALDONI A, GUERRO B, SPINILLO A: The ‘talent’ multicenter trial: efficacy of tinidazole, metronidazole, and tinidazole + acidic vaginal gel in the treatment of B. vaginosis. 86th World Congress for Infectious and Immunological Diseases in Obstetrics and Gynecology, Venice, Italy (8 – 11 November 2003).
  • EKGREN J, NORLING BK, DEGRE M, MIDTVEDT T: Comparison of tinidazole given as a single dose and on 2 consecutive days for the treatment of nonspecific bacterial vaginosis. Gynecol. Obstet. Invest. (1988) 26:313-317.
  • PAAVONEN J, VESTERINEN E, PUROLA E et al.: Single dose of tinidazole in the treatment of vaginal discharge. Scand. J. Urol. Nephrol. Suppl. (1984) 86:237-240.
  • VAN DER MEIJDEN WI: Treatment of non-specific vaginitis with a single dose of tinidazole. Scand. J. Infect. Dis. (1983) 40:85-89.
  • BAGNOLI VR, KESSELRING GL: Multicenter, double-blind, randomized, comparative study between secnidazole (single dose of 2g) and tinidazole (single dose of 2g) in the treatment of nonspecific vaginitis. RBM Ginecol. E. Obstet. (1992) 3:198-202.
  • VUTYAVANICH T, PONGSUTHIRAK P, VANNAREUMOL P, RUANGSRI RA, LUANGSOOK P: A randomized double-blind trial of tinidazole treatment of the sexual partners of females with bacterial vaginosis. Obstet. Gynecol. (1993) 82:550-554.
  • BARDI M, MANENTI G, MATTIONI D, LASALA L: Activity of some metronidazole analogs on vaginitis caused by Haemophilus vaginalis: comparative clinical study. Gior. It. Ost. Gin. (1982) 4:503-506.
  • MARTINS N: Ambulatory diagnosis of vaginitis: evaluation of 4903 patients treated with tinidazole with a single oral dose. Rev. Bras. Clin. Terap. (1985) 14:94-98.
  • IMPRODA L, NOBLER L, CHIEREGO C, IACONO A, SICA C, RULLO F: Is it necessary to treat the partner of a woman affected by bacterial vaginosis? Giorn. It. Ost. Gin. (1994) 78:371-373.
  • VILLAGRANA-ZESATI R, REYNA-FIGUEROA J, ORTIZ-IBARRA J: Short-term therapy for mixed vaginal infections. Int. J. Gynaecol. Obstet. (2006) 92:149-150.
  • BARDI M, MANENTI G, MATTIONI D, LASALA L: Activity of some metronidazole analogs on vaginitis caused by Haemophilus vaginalis: comparative clinical study. Gior. It. Ost. Gin. (1982) 4:503-506.
  • DE LA CABADA FJ: Treatment of vaginitis due to Gardnerella vaginalis with tinidazole. Invest. Med. Int. (1988) 15:66-71.
  • SANZ SANZ F, DEL PALACIO HERNANZ A, SANCHEZ E et al.: Double-blind randomized comparative trial: ornidazole (Tiberal®) versus tinidazole (Falsigin®) for the treatment of non-specific vaginitis. Chemioterapia (1985) 4(3):218-221.
  • PIOT P, VAN DYCK E, GODTS P, VANDERHEYDEN J: A placebo-controlled, double-blind comparison of tinidazole and triple sulfonamide cream for the treatment of nonspecific vaginitis. Am. J. Obstet. Gynecol. (1983) 147:85-89.
  • HEIKKINEN J, VUOPALA S: Anaerobic vaginosis: treatment with tinidazole vaginal tablets. Gynecol. Obstet. Invest. (1989) 28:98-100.
  • BAYLSON FA, NYIRJESY P, WEITZ MV: Treatment of recurrent bacterial vaginosis with tinidazole. Obstet. Gynecol. (2004) 104:931-932.
  • SCHWEBKE JR, PROVAN A, BARRIENTES F: Treatment of resistant Trichomonas vaginalis and bacterial vaginosis with tinidazole. International Society of Sexually Transmitted Diseases Research 15th Biennial Congress, Ontario, Canada (27 – 30 July 2003):0021 (Abstract).
  • MILEK E, NEDELKOVA E: Single-dose therapy with tinidazole in trichomoniasis. Curr. Med. Res. Opin. (1974) 2(3):169-177.
  • WALLIN J, FORSGREN A: Tinidazole – a new preparation for T. vaginalis infections. II. Clinical evaluation of treatment with a single oral dose. Br. J. Vener. Dis. (1974) 50(2):148-150.
  • GULMEZOGLU AM, FORNA F: Interventions for treating trichomoniasis in women. Cochrane Database Syst. Rev. (2003) 2:CD000218.
  • AIMAKHU V: Vaginal trichomoniasis: one stat dose of tinidazole compared with a seven day course of metronidazole. W. Afr. Med. J. (1975) 24:97-100
  • ANJANEYULU R, GUPTE SA, DESAI DB: Single-dose treatment of trichomonal vaginitis: a comparison of tinidazole and metronidazole. J. Int. Med. Res. (1977) 5:438-441
  • CHAISILWATTANA P, BHIRALEUS P, PATANAPARNICH P, BHADRAKOM C: Double blind comparative study of tinidazole and ornidazole as a single dose treatment of vaginal trichomoniasis. J. Med. Assoc. Thai. (1980) 63(8):448-453.
  • GABRIEL G, ROBERTSON E, THIN RN: Single dose treatment of trichomoniasis. J. Int. Med. Res. (1982) 10(2):129-130.
  • HILLSTROM L, PETTERSSON L, PALSSON E, SANDSTROM SO: Comparison of ornidazole and tinidazole in single-dose treatment of trichomoniasis in women. Br. J. Vener. Dis. (1977) 53(3):193-194.
  • LYNG J, CHRISTENSEN J: A double-blind study of the value of treatment with a single dose tinidazole of partners to females with trichomoniasis. Acta. Obstet. Gynecol. Scand. (1981) 60(2):199-201.
  • MATI JK, WALLACE RJ: The treatment of trichomonal vaginitis using a single dose of tinidazole by mouth. East Afr. Med. J. (1974) 51(12):883-888.
  • O-PRASERTSAWAT P, JETSAWANGSRI T: Split-dose metronidazole or single-dose tinidazole for the treatment of vaginal trichomoniasis. Sex. Transm. Dis. (1992) 19(5):295-297.
  • MANORAMA HT, SHENOY DR: Single-dose oral treatment of vaginal trichomoniasis with tinidazole and metronidazole. J. Int. Med. Res. (1978) 6(1):46-49.
  • REES PH, MCGLASHAN HE, MWEGA V: Single-dose treatment of vaginal trichomoniasis with tinidazole. East Afr. Med. J. (1974) 51:782-785.
  • MULLER M, LOSSICK JG, GORRELL TE: In vitro susceptibility of Trichomonas vaginalis to metronidazole and treatment outcome in vaginal trichomoniasis. Sex. Transm. Dis. (1988) 15(1):17-24.
  • SCHMID G, NARCISI E, MOSURE D, SECOR WE, HIGGINS J, MORENO H: Prevalence of metronidazole-resistant Trichomonas vaginalis in a gynecology clinic. J. Reprod. Med. (2001) 46(6):545-549.
  • SOBEL JD, NAGAPPAN V, NYIRJESY P: Metronidazole-resistant vaginal trichomoniasis – an emerging problem. N. Engl. J. Med. (1999) 341(4):292-293.
  • GILLETTE H, SCHMID G, MOSURE D et al.: Metronidazole-resistant Trichomonas vaginalis: a case series, 1985 – 1998. Proceedings of the International Society of Sexually Transmitted Diseases Research, Denver, USA (11 – 14 July 1999).
  • HAGER WD: Treatment of metronidazole-resistant Trichomonas vaginalis with tinidazole: case reports of three patients. Sex. Transm. Dis. (2004) 31(6):343-345.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.